Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report.
- Resource Type
- Article
- Source
OncoTargets & Therapy . Jul2022, Vol. 15, p831-836. 6p.- Subject
- *
CRIZOTINIB
*ADENOCARCINOMA
*LUNGS
*NUCLEOTIDE sequencing
*THERAPEUTICS - Language
- ISSN
- 1178-6930